Showing results (831-840 of 6,303) with videos related to

Sort By:
Pageof 631
Diabetes, Obesity & Metabolism|March 3, 2020
Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover studyMunehide Matsuhisa, Yasushi Takita, Risa Nasu, et al.
Diabetes, Obesity & Metabolism|April 7, 2020
Propensity score methods in real-world epidemiology: A practical guide for first-time usersYoon Kong Loke, Katharina Mattishent
Diabetes, Obesity & Metabolism|April 7, 2020
Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applicationsColin P O'Leary, Matthew A Cavender
Diabetes, Obesity & Metabolism|April 7, 2020
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) projectBjörn Runesson, Yang Xu, Abdul R Qureshi, et al.
Diabetes, Obesity & Metabolism|March 21, 2020
Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort studyEric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, et al.
Diabetes, Obesity & Metabolism|March 14, 2020
Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin: A subanalysis from a randomized, placebo-controlled trial (RELEASE study)Stefanie A de Boer, Melanie Reijrink, Wayel H Abdulahad, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Twelve-year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United StatesGhadeer K Dawwas, Charles E Leonard, Mahek Garg, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) RegisterAlice P S Kong, Thomas Lew, Eric S H Lau, et al.
Diabetes, Obesity & Metabolism|April 3, 2020
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary diseaseMohamad Isam Saeed, Josefin Eklöf, Imane Achir, et al.
Diabetes, Obesity & Metabolism|December 4, 2019
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetesJuris J Meier, Björn A Menge, Nina Schenker, et al.
Pageof 631